Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Primary Immunization Age: Adults |
Dose: Subcutaneous Injection – 0.5 ml Frequency: single dose Note: Protective antibody levels may be achieved within 7 to 10 days after vaccination. |
|
Indication: Revaccination Age: Adults Condition: Antibody level has rapidly declined after the first vaccination |
Dose: Subcutaneous Injection – 0.5 ml Frequency: single dose Note: Revaccination is considered after primary immunization within 3 to 5 years. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: all age groups |
Dose: Vaccine – 0.5 mL Frequency: single dose Note: administered subcutaneously |
|
Indication: Primary Immunization Age: from 2 years of age |
Dose: Vaccine – 0.5 ml Frequency: single dose Note: administered subcutaneously; protective antibody levels may be achieved within 7 to 10 days after vaccination |
Administration
- Give intramuscularly only
- Use proper technique
Side Effect
- Metabolism and nutrition disorders Common appetite lost
- Psychiatric disorders Very common irritability
- Nervous system disorders Very common drowsiness
- headache
- Uncommon dizziness
- Gastrointestinal disorders Common gastrointestinal symptoms eg nausea
- vomiting and diarrhea
- Musculoskeletal and connective tissue disorders Common myalgia
- General disorders and administration site conditions Very common pain and redness at the injection site
- fatigue
- Common swelling at the injection site
- fever
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Other vaccines
|
Can be administered at the same time, but at different injection sites
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Previous severe allergic reaction
|
Risk of anaphylaxis
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep out of the reach and sight of children .Store and transport at 2°C to 8°C. Do not freeze Protect from light .The vaccine should be used within 30 minutes after reconstitution
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.